Identification of new susceptibility loci for pancreatic cancer in the Japanese populatio
Not Applicable
Recruiting
- Conditions
- Patients with pancreatic cancer
- Registration Number
- JPRN-UMIN000052651
- Lead Sponsor
- Asahikawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 105
Inclusion Criteria
Not provided
Exclusion Criteria
<Patients with pancreatic cancer> (1) Patients with histologically confirmed endocrine neoplasms (2) Patients with serious underlying diseases or complications that would make it difficult to participate in the study. (3) Patients who no longer meet the above selection criteria after enrollment or who are newly found to be in conflict with the exclusion criteria. (4) Patients who are judged to be inappropriate as research subjects by the physician in charge. <Volunteer> None in particular
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Search for germline mutations using peripheral blood mononuclear cells (all cases).
- Secondary Outcome Measures
Name Time Method (1) Frequency of detection of multiple lesions including pancreatic cysts by MRI and other imaging modalities (all cases) (2) Functional analysis of somatic mutations and drug responsiveness using primary cells in tumor tissues (in surgical cases where fresh tumor tissues can be secured prior to fixation)